National High-tech Enterprise Awarded for 16 consecutive years Top 20 Chinese Pharmaceutical R&D Companies Awarded for 3 consecutive years 70+ clinical approval & Production approval & New Drug Certificates 10+ International Registration (USDMF, CEP, etc. ) Submitted 100+ Technology Transfer 30+ Series products Industrialed

20+ New Invention Patents Applied 2API products activated in CDE 5 finished formulation products approved for production license Shanghai Branch was established. Strengthen business expansion and layout

• Obtain the first CEP certificate • Obtain CNAS certificate • Submit MAH registration application for the first time and obtain B certificate • Two API varieties have been approved by CDE and transferred to A

• Jinghai Industrial Park R&D Center Operated • Strategic Partnership with Zezheng Pharmaceutical Established

• Subsidiary HMYA Established, International Business Operated Independently • EU & FDA Application Submitted • Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected) • CSAIII Pilot • T100 New Technology & New Product Innovation Action Outstanding Enterprise Awarded

• Strategic Partnership with PPC Group Established • Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected)

• Strategic Partnership with Porton Pharmaceutical Established • Top 20 Chinese Pharmaceutical R&D Companies Awarded

• Subsidiary HMY Established, CRO Business Operated Independently

• Subsidiary HMT Established, The Raw Materials & Intermediates Business Operated Independently • Employee Stock Ownership Platform Established, Shareholding Reform Finished

• The First Patent Certificate Awarded

• The First New Drug Certificate Acquired • Technology R & D Institution (Beijing) Awarded • Audited by Foreign Clients

• Equity Investment in Shandong Confucius Pharmaceutical

• Strategic Partnership with Peking Chemical Heng-ye Established

• National High-tech Enterprise Awarded

• New Drug R & D Center Established

• Hope Pharmaceutical Founded